Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · NHL

Stimulator, Electrical, Implanted, For Parkinsonian Symptoms

Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic Activa Parkinson's Control Therapy is indicated for adjunctive therapy in reducing some of the symptoms of advanced, levodopa-responsive Parkinsons disease that are not adequately controlled with medication.

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA supplementOct 30, 2026FDA
Boston Scientific CorpPMA supplementOct 15, 2026FDA
Boston Scientific CorpPMA supplementSep 22, 2026FDA
Boston Scientific CorpPMA supplementSep 13, 2026FDA
Boston Scientific CorpPMA supplementAug 10, 2026FDA
Boston Scientific CorpPMA supplementJul 16, 2026FDA
Boston Scientific CorpPMA supplementJul 10, 2026FDA
Boston Scientific CorpPMA supplementMay 28, 2026FDA
Boston Scientific CorpPMA supplementMay 18, 2026FDA
Boston Scientific CorpPMA supplementMay 13, 2026FDA
Boston Scientific CorpPMA supplementJan 22, 2026FDA
Boston Scientific CorpPMA supplementDec 17, 2025FDA
Boston Scientific CorpPMA supplementDec 10, 2025FDA
Boston Scientific CorpPMA supplementSep 19, 2025FDA
Boston Scientific CorpPMA approvalDec 8, 2017FDA
Source information

Follow the FDA links to view the original records.

All device categories